Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Altering SSAT affects fat metabolism and body fat in mice.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Men with testicular cancer were less likely to experience baldness and severe acne.

Shift work disrupts the body's natural clock, leading to health problems.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.